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BACKGROUND: Tobacco smoking plays an important role in nasopharyngeal carcinoma (NPC) risk. The Wingless-related integration site (WNT) 
Inhibitory Factor 1 (WIF1) as one of the tumor suppressor 
gene (TSG), functions to control cell proliferation through 
suppression of WNT signaling pathway. WIF1 methylation 
is one of epigenetic mechanisms which causes overactivated 
of WNT pathway in NPC development. WIF1 methylation 
from buffy coat related to smoking status and NPC risk is 
not known yet.
METHODS: This  was  a  nested  case-control  study 
involving  39  newly  diagnosed  NPC  patients  and 
40 healthy controls. All subjects were enrolled at Dr. 
Sardjito Hospital, Yogyakarta. Subjects were male, with 
known smoking status, duration, and quantity of cigarette 
consumed.  Parallel  DNA  isolated  from  buffy coat 
was used for WIF1 DNA methylation analysis, by using 
methylation-specific PCR (MSP) method. Chi-square 
analysis was used to determine distribution of differences 
among groups. Two tailed p-value≤0.05 was considered as 
statistically significant.
RESULTS: No significant difference between WIF1 
methylation of cases and controls (p=0.30), nor smoking 
habit among smokers (p=0.51) and non-smokers (p=0.43). 
CONCLUSION: WIF1 methylation from buffy coat could 
not be used as an NPC marker nor as a smoking behavior 
marker.
KEYWORDS: buffy coat, cigarette smoking, methylation, 
nasopharyngeal carcinoma, WIF1
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Abstract
Introduction
Nasopharyngeal carcinoma (NPC) is an epithelial cell 
malignancy located on the surface of the nasopharynx 
located after the nostrils and connects them to the throat.
(1) The global NPC incidence is 1.7/100,000 per year. The 
estimated incidence of NPC in Indonesia is 8.3/100,000 
per year, which makes it the fifth most common carcinoma 
among men in Indonesia. NPC is more common in men 
than in women with a ratio of 2.5:1.(2) Etiology of NPC 
is generally divided into three causes: Epstein-Barr virus 
(EBV) infection,  carcinogenic  exposure  and  genetic 
susceptibility. NPC will not occur if a person has only 
one factor, so there is no dominant factor of vulnerability. 
Carcinogenic exposures can be obtained from the 
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environment. One of the most common carcinogenic 
exposures of the environment is cigarette smoking, which 
reported as NPC common risk in high and low incidence 
population.(3)
 NPC has been reported to contain more methylation 
than mutations, when compared with other types of 
tumors.(4,5) Wingless-related integration site (WNT) 
Inhibitory Factor 1 (WIF1) is one of the DNA segments 
that frequently methylated and affected by cigarette 
smoking. It was reported that cigarette smoking increased 
the risk of WIF1 methylation by 88% in lung cancer.(6) 
WIF1  is  one  of  the  tumor  suppressor  genes  (TSGs) 
that  controls cell proliferation by suppressing WNT gene 
expression (oncogene). WNT controls β-catenin expression. 
Overexpression of β-catenin leads to nasopharyngeal cancer 
progression.(7) WIF1 methylation was reported to be found 
in 61.2% of biopsies and brushing samples from NPC 
patients collected at Dr. Sardjito Hospital in Yogyakarta.
(8) Until currently, there was no report that correlates 
WIF1 methylation, smoking behavior and nasopharyngeal 
carcinoma. 
 Tumor tissue is considered as the best source of 
information, due to tumor clonality. Particularly for NPC, 
the small size of tissue biopsy and the impact of preserving 
the tissue in formalin may limit the use of formalin-fixed 
paraffin embedded (FFPE) tissue for epigenetic studies.
(9) The use of other type of samples such as nasopharynx 
brushings  and  peripheral  blood  for  methylation  studies 
were suggested as well due to the less invasiveness 
procedures.(8,10) 
 Previous report from our group showed that Ras 
Association Domain Family Member 1A (RASFF1A) 
and Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
DNA methylation could be observed in buffy coat of NPC 
peripheral blood samples.(9) This was supported by an 
epigenome-wide association study (EWAS) of smoking 
conducted among twin and family, using DNA-derived 
peripheral blood collected as dried blood spots . The EWAS 
study revealed 39 CpGs differently methylated on never, 
former and current smokers.(11) These previous studies 
showed that DNA methylation could be detected from 
peripheral blood-derived DNA.(9,11)
 Within this study, we discuss the detection of WIF1 
methylation from buffy coat of peripheral blood, and 
further analysed its correlation with smoking behavior 
comparing NPC and healthy controls. Identification of 
WIF1 methylation in this study was conducted by using 
qualitative methylation-specific PCR (MSP) which broadly 
used to detect DNA methylation of known gene. 
Methods
Study Sample 
This was a nested case-control study, taken from the 
previous hospital-based case control study 2012-2014 at Dr. 
Sardjito General Hospital, Yogyakarta. Cases were those 
who newly diagnosed and histopathologically confirmed 
NPC. Healthy controls were those who declared healthy at 
the point of recruitment and never been diagnosed with any 
type of cancer. Data on clinical status, demographic, and 
smoking behavior including smoking status (smoker and 
not smoker), smoking duration and smoking quantity were 
collected in database. Peripheral blood samples, including 
separated buffycoat were collected from subjects and stored 
at -80oC until used. 
 The inclusion criteria for this study was male, age 
conformity between case and control (±5 years) and had 
smoking status data (quantity and duration of smoking). 
Sample with poor quality and quantity of DNA were 
excluded. Further, this study could include 40 controls and 
39 cases. Smoking status was determined as those who 
actively smoking until diagnosed, whole non smoker were 
those who never smoked regularly for at least a year.
 The DNA used in this study were isolated from 
buffycoat,  purified  by  using  QIAamp  DNA  Blood  Mini 
Kit (Qiagen, Hilden, Germany), and further, kept in -20°C 
until used.
 This study was approved by the Medical and Health 
Research Ethics Committee of the Faculty of Medicine, 
Public Health and Nursing, Universitas Gadjah Mada, 
Yogyakarta, Indonesia with reference number KE/FK/0078/
EC/2018.
WIF1 Methylation Detection
DNA underwent bisulfite modification using Cells-to-
CpG™ Bisulfite Conversion Kit (Applied Biosystem, 
California, USA). Modified DNA could be stored for a long 
time at -20°C. WIF1 methylation detection was analyzed 
using MSP methods, with methylation forward primer: 
5’- CGT TTT ATT GGG CGT ATC GT -3’ , methylation 
reverse primer: 5’ - ACT AAC GCG AAC GAA ATA CGA 
-3’ (12); unmethylated forward primer: 5’- TTT TTG 
TTG TTT TTA TTT TTG TTT GT -3’, and unmethylated 
reverse primer: 5’- TCC CAT TTA AAC AAC TAA ACA 
CA -3’.(13) MSP for methylation used Amplitaq Gold 360 
(Thermofisher, California, USA). MSP for unmethylation 
used Invitrogen Platinum Taq Polymerase (Thermofisher). 
MSP process was conducted by using Applied Biosystems 
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ProFlex PCR System (Thermofisher). Unmethylated and 
methylated WIF1 were observed in 2% agarose gel (in TAE 
buffer) with 148 bp and 162 bp DNA band, respectively.
Statistical Analysis
The proportions of methylation between case-control/
smoking status groups were observed using Chi-Square 
analysis. A two tailed p-value of ≤0.05 was considered as 
statistically significant. Statistical analyses used IBM SPSS 
statistics v23.
Characteristic of subjects are shown in Table 1. No 
difference was found between mean of age and smoking 
status between cases and controls (p>0.05). The average 
duration of smoking and average cigarette consumption 
were also similar between cases and controls (p>0.05).
 Unmethylated and methylated WIF1 are shown 
as bands at 148 bp and 162 bp, respectively (Figure 1). 
Differences of WIF1 methylation between cases and 
controls are shown in Table 2. Overall, WIF1 methylation 
was observed in 20 controls (50%) and 15 cases (42.90%) 
(p=0.30) as shown in Table 2. Table 3 shows a comparison 
of WIF1 methylation between smokers and non-smokers, 
regardless of their NPC status. Overall, no significant 
difference was observed between both groups (p=0.79)
 Stratified analysis of smoking behavior related to 
WIF1 methylation correlated with NPC risk is shown in 
Results
Control
(n = 40)
Case
(n = 39) p *
Mean ± SD (year) 49.58 ± 2.56 50.58 ± 2.38 0.79
Smoker 19 19
Non-smoker 21 20
Mean ± SD (year) 28.89 ± 13.07 33.21 ± 2.99 0.47
Mean ± SD (year) 8.95 ± 1.30 12.89 ± 1.93 0.21
Type 2 0 1
Type 3 0 38
WHO type 
0.91
Age
Smoking status
Smoking duration
Cigarette/day
Variable
Table 1. Subject characteristics.
Table 4. Neither the smokers nor non-smokers group had 
significant  differences  in the  WIF1  methylation  status 
based on their NPC status. WIF1 methylation was detected 
among 7 (36.8%) smoker NPC patients and 9 (47.4%) 
smoker healthy people with Odds Ratio (OR)=0.65 and 
p=0.51. WIF1 methylation was detected among 8 (40%) 
non-smoker NPC patients and 11 (52.4%) non-smoker 
healthy people with OR=0.606 and p=0.43.
*chi-square test; p≤0.05 considered as statistically different.
Discussion
NPC is a malignancy reported to contain more DNA 
methylation than mutations, compared to other types of 
cancer.(4,5) Similar to many cancers, tobacco smoking 
has been reported as a risk factor of NPC in low and high 
incidence populations.(3,12) Methylation of WIF1 was 
reported to be highly detected in tissue of NPC (8,13), 
while the association between methylation status of WIF1 
in peripheral blood and smoking behavior was reported only 
among lung cancer patients.(6) 
 The use of peripheral blood as an alternative to tumor 
tissues has been reported in different diseases, including 
cancers (14), diabetes (15) and cardiovascular disease (16). 
A study on colorectal cancer reported that methylation 
from whole blood could be used as a biological marker 
for diagnostic purpose. They reported that methylation of 
Aldehyde Oxidase 1 (AOX-1), Retinoic Acid Receptor-b2 
(RARB2), Ras Like Estrogen Regulated Growth Inhibitor 
(RERG), Adam Metallopeptidase with Thrombospondin 
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A B
Figure 1. Methylation-specific PCR (MSP) result of WIF1 methylation detection. A: methylated-specific primer used for methylation 
detection; B: unmethylated-specific primer used for unmethylation detection. Sample 1 is unmethylation sample, sample 2 is methylated 
sample, and sample 3 is partially methylated sample and considered as methylated sample. 
WIF1  Methylation Status  Control Case p *
Methylated 20 (50%) 15 (42.9%)
Unmethylated 20 (50%) 24 (61.5%)
0.3
Table 2. WIF1 methylation status and NPC status.
Methylated Unmethylated 
Smoker 16 (45.7%) 22 (38.5%)
Non-smoker 19 (54.3%) 22 (61.5%)
p *
WIF1  Methylation Status
0.79
Smoking Status
Table 3. WIF1 methylation and smoking behavior.
*chi-square test; p≤0.05 considered as statistically different.
*chi-square test; p≤0.05 considered as statistically different.
Type 1 Motif 9 (ADAMTS9), Interferon Regulatory Factor 
4 (IRF4), and Forkhead Box E1 (FOXE-1) were higher 
among patients compared to healthy controls.(17) An 
EWAS in breast cancer, compared methylation of DNA 
from buffy coat of breast cancer patients and healthy people. 
The results showed that breast cancer patients had a higher 
number of methylated genes compared to healthy people.
(18) Previous report from our group has shown that gene 
methylation could be detected in the buffycoat from NPC 
patient.(9) Further, both our studies may highlighted the 
capacity of buffy coat to be used in DNA methylation study. 
A study showed in the meta analysis, the superior detection 
of of RASFF1A methylation for NPC diagnosis from NPC 
tissue compared to nasopharyngeal brushing and even less 
in peripheral blood.(10) 
 Within this study, in comparing NPC and control 
subjects, we did not find difference of WIF1 methylation 
status by using qualitative MSP. Therefore, in this study, 
WIF1 methylation status from buffy coat could not be used 
as a marker for the nasopharyngeal cancer. Previous study 
recommended a combination of five methylation marker 
including  WIF1,  RASSF1A,  p16,  Checkpoint with Forkhead 
and Ring Finger Domains (CHFR), and Retinoblastoma-
Interacting Zinc-Finger Protein 1 (RIZ1) to predict NPC 
risk.(8) In the term of sampling invasiveness, buffy coat and 
nasopharynx brushings, known to be less invasive, could 
determine WIF1 methylation as well as biopsy sample by 
using multiplex MSP.(19) The WIF1 gene was found to 
be methylated in the nasopharyngeal cancer cell culture 
(C666-1). In this cell culture, WIF1, nemo like kinase 
(NLK),  and adenomatous  polyposis  coli  (APC)  genes 
were also methylated, resulting in the decreased expression 
of these three genes.(20) Other studies have shown that 
the methylation of WIF1, APC, O-6-Methylguanine-DNA 
Methyltransferase (MGMT) and RASSF12A genes from 
peripheral blood samples has a sensitivity of 86.5% and a 
specificity of 92.1% in detecting colorectal cancer.(21) 
 Cigarette smoke contains chemical compounds that 
contributes to carcinogenesis, e.g., arsenic, formaldehyde, 
aromatic amines, N-nitrosamines, and volatile hydrocarbon. 
Those carcinogens damage DNA strains and recruited DNA 
repair proteins, one of which is DNA methyltransferase  1 
(DNMT1), which causes DNA methylation.(22) Our study 
showed no difference on WIF1 methylation between non-
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Case Control Case Control 
Unmethylated 12 (63.2%) 10 (52.6%) 12 (60%) 10 (47.6%)
Methylated 7 (36.8%) 9 (47.4%) 8  (40%) 11 (52.4%)
p *
0.65 0.51 0.61 0.43
WIF1  Methylation Status
Smoker
OR p *
Non-smoker
OR
Table 4. Stratification analysis of WIF1 promoter gene methylation in case-control group of smoker and non-smoker subject.
*chi-square test; p≤0.05 considered as statistically different.
smokers  and  smokers,  regardless  of  their  NPC  status. 
Study on non-small cell lung cancer (NSCLC) showed that 
WIF1 methylation correlated with bad prognosis instead 
of smoking habit. WIF1 methylation in NSCLC patients 
increased the risk of recurrence compared to unmethylated 
WIF1.(23) WIF1 methylation also correlated with smoking 
habit in Het-1A, an esophageal epithelial cell line. WIF1 
expression became downregulated and correlated to 
methylation in Het-1A treated with mainstream smoke 
extract (MSA) and side-stream smoke extract (SSE) for 6 
months.(24) Our prior study on RASSF1A and CDKN2A 
methylation  status  in peripheral  blood  showed  no 
association with smoking behavior.(9) Similarly, in our 
study, WIF1 methylation of peripheral blood cell-derived 
DNA could not act as a smoking behavior marker. Regarding 
the suggested pattern by Lee and Pausova, correlation of 
smoking behavior and DNA methylation still needs to be 
observed in NPC by using other target genes in the TSG and 
oncogenes pathways.(22)
 DNA methylation using qualitative approach might 
contributed to the result of the study, as it only assessed 
the presence and the absence of MSP product. Previous 
study showed that compared to bisulfite sequencing as gold 
standard for DNA methylation detection, qualitative MSP 
found less agreement than quantitative high resolution 
mass-spectrometry based approach (mass-ARRAY). This 
protocol yielded significant difference between high degree 
of Inhibitor of DNA Binding 4 (ID4) gene methylation of 
acute myeloid leukemia (AML) patients and low degree of 
ID4 gene methylation or unmethylation of healthy controls.
(25) For further study, we propose the use of quantitative 
approach or at the minimum semi-quantitative assay such 
as high resolution melting (HRM), to further determine the 
role of smoking habit to the pathogenesis of NPC related to 
methylation of regulating genes. 
 Smoking behavior is one of many potential 
environmental factors that correlate with NPC. There 
are other environmental factors that may generate 
DNA methylation, such as diet, physical activity, drug 
consumption, and occupational exposure.(26,27) In future 
studies, it is suggested to do further analysis that discuss the 
association of methylation status quantitatively and potential 
environmental factors in a larger set of populations.
Conclusion
We concluded that WIF1 methylation was found in the 
blood cell-derived DNA. WIF1 methylation from the DNA 
buffy coat could not be used as either NPC nor smoking 
behavior markers. 
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